相关实验视频

Updated: Jul 5, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

对多囊性卵巢综合征的潜在治疗基因的基于生物信息学的分析

Ying Liu¹, Jinwei Yu², Jing Li³

¹The Third Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China. Liuying7780@163.com.

Cellular and molecular biology (Noisy-le-Grand, France)

|April 28, 2024

概括

这项研究确定了三种关键基因 (RPL13,LEP和ANXA1) 在多囊性卵巢综合征 (PCOS) 中表达高. 这些基因显示出作为PCOS的诊断标记物和治疗点的潜力.

科学领域:

基因组学就是基因组学.
生物信息学是一种生物信息学.
内分泌学在内分泌学.

背景情况:

多囊卵巢综合征 (PCOS) 是一种复杂的内分泌疾病.
识别关键基因及其功能对于理解PCOS病原体至关重要.
现有的研究需要进一步探索PCOS的遗传标记.

研究的目的:

在PCOS中使用基因芯片数据选差异表达基因 (DEGs).
调查在PCOS中发现的DEGs的生物功能和临床意义.
确定PCOS的潜在诊断和治疗点.

主要方法:

从GEO数据库中利用基因芯片数据 (GSE5090) 来选DEGs.
采用了目标基因预测软件和功能丰富分析.
使用STRING和Cytoscape来识别关键基因的构建蛋白质-蛋白质相互作用 (PPI) 网络.

主要成果:

确定了与PCOS相关的十七种DEG,在PCOS相关的功能中显著丰富.
突出显示免疫系统标志物,其中18个显示显著差异.
通过PPI网络分析确定了RPL13,LEP和ANXA1作为关键基因.
开发了PCOS风险的预测模型,通过ROC曲线证实了高诊断准确度.

结论:

这项研究是第一个使用生物信息学来确认PCOS患者RPL13,LEP和ANXA1的高表达的研究.
RPL13,LEP和ANXA1代表了PCOS的潜在诊断生物标志物.
这些关键基因可能成为未来PCOS治疗干预措施的可行目标.

更多相关视频

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...